InvestorsHub Logo
Followers 0
Posts 327
Boards Moderated 0
Alias Born 04/30/2020

Re: None

Thursday, 04/30/2020 8:31:49 AM

Thursday, April 30, 2020 8:31:49 AM

Post# of 40502
Inovio Pharmaceuticals Inc. (INO) said Thursday it has received another grant from the Coalition for Epidemic Preparedness Innovations , or CEPI, an Oslo -based organization, to help it expend manufacturing of its COVID-19 vaccine candidate. Plymouth Meeting, Pa. -based Inovio said CEPI has given it $1.3 million to support large-scale manufacturing of INO-4800, its DNA based vaccine which is in Phase 1 clinical testing in the U.S. That brings the total it was been awarded by CEPI to $17.2 million . The company is working with German contract manufacturer Richter-Helm BioLogics GmbH & Co. KG , which already makes its vaccine for HPV. The company is aiming to move to Phase 2/3 efficacy trials this summer. Inovio has 15 DNA medicine clinical programs currently in development, but has not had a product approved for treatment. Shares fell 6% premarket, but have gained 316% in the year to date, while the S&P 500 has fallen 10%.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News